ALG Q1 2026 Earnings EPS Surpasses Estimates by 828 ANI Pharmaceuticals Q1 2026 Earnings Major EPS Beat Belies Subdued Market Response EGO Q1 2026 Earnings EPS Surges Past Estimates by 33 Amid Operational Gains RCAT Q1 2026 Earnings EPS Misses Estimates by 7147 Amid Continued Investment in Drone Technology PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus